Loading HASI…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("HASI","financials")Full statements spill as a table. For one cell: =jivedata("HASI","Revenue") or =jivedata("HASI","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
HASI • CIK 0001561894
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Gain (Loss) on Disposition of Assets | $68,637 | $80,341 | $65,089 | $77,175 |
| Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | $41,404 | $25,948 | $-27,184 | $-16,969 |
| Income (Loss) from Equity Method Investments | $140,974 | $247,878 | $300,667 | $154,654 |
| Revenues | $319,871 | $383,595 | $400,502 | $462,892 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $182,378 | $273,826 | $273,483 | $137,685 |
| Income Tax Expense (Benefit) | $31,621 | $70,198 | $85,247 | $49,388 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $150,757 | $203,628 | $188,236 | $88,297 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $1,921 | $3,591 | $3,689 | $2,148 |
| Net Income (Loss) Attributable to Parent | $148,836 | $200,037 | $184,547 | $86,149 |
| Weighted Average Number of Shares Outstanding, Basic | 101,844,551 | 115,548,087 | 122,975,541 | 130,294,822 |
| Weighted Average Number of Shares Outstanding, Diluted | 109,467,554 | 130,501,006 | 138,183,870 | 143,394,862 |
| Interest Expense | $171,008 | $242,364 | $292,404 | $334,724 |
| Labor and Related Expense | $64,344 | $81,319 | $92,460 | $111,368 |
| General and Administrative Expense | $31,283 | $32,905 | $30,677 | $32,939 |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | $0 | $0 | $0 | $-500 |
| Net Income (Loss) Available to Common Stockholders, Basic | $147,800 | $198,500 | $182,629 | $84,729 |
| Interest on Convertible Debt, Net of Tax | $7,500 | $12,600 | $12,031 | $9,831 |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted | — | $0 | $0 | $500 |
| Net Income (Loss) Available to Common Stockholders, Diluted | $155,300 | $211,100 | $194,660 | $94,060 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 612,742 | 880,352 | 1,124,309 | 1,200,250 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $62,632 | $129,758 | $110,218 | $249,921 |
| Equity Method Investments | $2,966,305 | $3,612,394 | $4,115,909 | $4,782,318 |
| Financing Receivable, after Allowance for Credit Loss | — | $2,895,837 | $3,280,046 | $3,145,473 |
| Accounts Receivable, Held-for-Sale, Not Part of Disposal Group, after Valuation Allowance | — | — | $113,938 | $72,804 |
| Accounts Receivable from Securitization | $218,946 | $248,688 | $299,739 | $332,201 |
| Other Assets | $77,112 | $108,210 | $191,824 | $283,389 |
| Assets | $6,552,350 | $7,080,245 | $8,187,965 | $8,940,993 |
| Accounts Payable and Accrued Liabilities | $163,305 | $275,639 | $380,702 | $390,304 |
| Long-term Line of Credit | $400,861 | $1,001 | $46,184 | $1,320 |
| Commercial Paper | $30,196 | $100,057 | $225,212 | $112 |
| Loans Payable | $727,458 | $407,978 | $386,391 | $476,395 |
| Senior Notes | — | — | $3,466,048 | $3,805,097 |
| Junior Subordinated Notes | — | — | $497,560 | $1,093,830 |
| Convertible Notes Payable | $609,608 | $619,543 | $403,438 | $404,330 |
| Liabilities | $4,410,725 | $4,675,170 | $5,530,096 | $6,290,943 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Common Stock, Value, Issued | $1,122 | $1,190 | $1,276 | $1,279 |
| Additional Paid in Capital, Common Stock | $2,381,510 | $2,592,964 | $2,849,597 | $2,857,351 |
| Retained Earnings (Accumulated Deficit) | $-303,536 | $-297,499 | $-323,071 | $-375,894 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $13,165 | $40,101 | $47,076 | $59,216 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $49,364 | $68,319 | $82,991 | $108,098 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $2,141,625 | $2,405,075 | $2,657,869 | $2,650,050 |
| Financing Receivable, Allowance for Credit Loss | $50,000 | $50,000 | $62,000 | $56,000 |
| Preferred Stock, Shares Authorized | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
| Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 |
| Common Stock, Shares Authorized | 450,000,000 | 450,000,000 | 450,000,000 | 450,000,000 |
| Common Stock, Shares, Issued | 112,174,279 | 118,960,353 | 127,644,496 | 127,945,053 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-100,890 | $75,075 | $-4,934 | $177,027 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $75,082 | $150,157 | $145,223 | $212,632 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $138,418 | $192,960 | $252,382 | $259,688 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $150,757 | $203,628 | $188,236 | $88,297 |
| Increase (Decrease) in Assets Held-for-sale | $-51,538 | $29,273 | $23,759 | $18,455 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $48,485 | $101,410 | $104,456 | $92,939 |
| Increase (Decrease) in Accrued Interest Receivable, Net | $44,105 | $78,639 | $68,471 | $93,584 |
| Increase (Decrease) in Derivative Assets and Liabilities | — | $-20,311 | $-24,515 | $-38,066 |
| Increase (Decrease) in Other Operating Assets | $3,027 | $10,704 | $4,731 | $13,668 |
| Net Cash Provided by (Used in) Operating Activities | $99,689 | $5,852 | $167,317 | $208,530 |
| Payments to Acquire Equity Method Investments | $869,412 | $396,613 | $447,938 | $842,372 |
| Proceeds from Equity Method Investment, Distribution, Return of Capital | $30,140 | $39,142 | $59,416 | $59,021 |
| Proceeds from Sale of Equity Method Investments | $0 | $9,472 | $0 | $0 |
| Payments to Acquire Finance Receivables | $1,338,860 | $667,140 | $1,043,493 | $1,058,125 |
| Proceeds from Collection of Finance Receivables | $197,784 | $600,652 | $705,675 | $877,429 |
| Proceeds from Sale of Finance Receivables | $7,634 | $171,991 | $8,344 | $15,282 |
| Proceeds from Sale of Real Estate Held-for-investment | $0 | $115,767 | $0 | $0 |
| Payments for Hedge, Investing Activities | $93,550 | $27,090 | $10,300 | $6,190 |
| Proceeds from Hedge, Investing Activities | $84,950 | $27,570 | $8,360 | $10,750 |
| Payments for (Proceeds from) Other Investing Activities | $-2,915 | $-204 | $65,333 | $-661 |
| Net Cash Provided by (Used in) Investing Activities | $-1,992,803 | $-131,192 | $-855,827 | $-1,015,014 |
| Proceeds from Lines of Credit | $1,177,000 | $1,296,792 | $1,180,000 | $1,442,000 |
| Repayments of Lines of Credit | $827,000 | $1,696,792 | $1,135,000 | $1,442,000 |
| Proceeds from (Repayments of) Commercial Paper | — | $70,000 | $125,500 | $-356,500 |
| Proceeds from Issuance of Secured Debt | $365,000 | $250,000 | $0 | $250,000 |
| Repayments of Secured Debt | $16,478 | $567,952 | $23,645 | $174,321 |
| Proceeds from Issuance of Unsecured Debt | $550,000 | $1,199,956 | $996,174 | $1,395,260 |
| Repayments of Convertible Debt | $143,748 | $0 | $200,000 | $0 |
| Repayments of Unsecured Debt | $0 | $400,000 | $700,000 | $1,050,000 |
| Proceeds from Issuance of Subordinated Long-term Debt | — | — | $500,000 | $1,100,000 |
| Proceeds from Convertible Debt | $402,500 | $0 | $0 | $0 |
| Proceeds from Issuance of Common Stock | $492,377 | $203,528 | $236,740 | $116,864 |
| Payments of Dividends | $159,786 | $192,269 | $209,776 | $219,990 |
| Payment for Debt Extinguishment or Debt Prepayment Cost | $0 | $0 | $8,395 | $19,692 |
| Payments of Debt Issuance Costs | $22,894 | $30,331 | $19,061 | $30,329 |
| Payments for Hedge, Financing Activities | $37,835 | $0 | $135,280 | $66,330 |
| Proceeds from Hedge, Financing Activities | — | — | $88,390 | $47,500 |
| Proceeds from (Payments for) Other Financing Activities | $-3,268 | $-969 | $-4,935 | $-1,855 |
| Net Cash Provided by (Used in) Financing Activities | $1,792,224 | $200,415 | $683,576 | $983,511 |
| Transfer to Investments | $144,603 | $32,564 | $0 | $0 |
| Accounts Receivable, Credit Loss Expense (Reversal) | $11,832 | $1,059 | $12,145 | $830 |
| Depreciation, Depletion and Amortization | $3,127 | $1,003 | $780 | $736 |
| Amortization of Debt Issuance Costs | $12,958 | $17,039 | $15,329 | $14,846 |
| Share-based Payment Arrangement, Noncash Expense | $18,386 | $23,151 | $29,885 | $35,349 |
| Income (Loss) from Equity Method Investments, Net of Dividends or Distributions | $108,025 | $179,747 | $81,875 | $-104,020 |
| Gain (Loss) on Securitization of Financial Assets | $43,542 | $70,685 | $40,043 | $61,345 |
| Gain (Loss) on Extinguishment of Debt | $0 | $0 | $-10,850 | $-20,499 |